State of Health Episode 18: Antibiotic Resistance: Investing in the Next Generation of Antibiotics

The State of Health continues the Antibiotic Resistance series with an episode featuring Henry Skinner, the CEO of the AMR Action Fund, a novel kind of investment fund that aims to catalyze the innovation ecosystem for novel antibiotics. Gunnar and Henry talk about the challenges of bringing new antibiotics to market, the difference between the AMR Action Fund and a traditional Biotechnology VC, and the pharmaceutical industry’s role in tackling antibiotic resistance. The conversation turns to emerging antibacterial technologies, antibiotic market dynamics and what success means for the AMR Action Fund in the long term. Earlier episodes in the Antibiotic Resistance Series are in the show’s feed!

Subscribe to the State of Health on Spotify and iTunes!